Company filings profile · CIK 0001402328
Sunshine Biopharma Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Sunshine Biopharma Inc. (SBFM): 19 filings in the last 90 days vs 19 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 3, 2026. Source-linked, daily-refreshed.
Material 8-K events — Sunshine Biopharma Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 16, 2026 | Item 5.07 | ↗ |
| Sep 11, 2026 | Other Events | ↗ |
| Aug 28, 2026 | Departure/Election of Directors or Officers | ↗ |
| Aug 3, 2026 | Other Events | ↗ |
| Jul 20, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 10, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| May 29, 2026 | Item 5.07 | ↗ |
| May 19, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 9, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch Sunshine Biopharma Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 2, 2026 | S-1 | FORM S-1 | ↗ |
| Sep 28, 2026 | DEF 14C | DEFINITIVE INFORMATION STATEMENT | ↗ |
| Sep 24, 2026 | DRS | ↗ | |
| Sep 16, 2026 | PRE 14C | PRELIMINARY PROXY | ↗ |
| Sep 16, 2026 | 8-K | Item 5.07 | ↗ |
| Sep 11, 2026 | 8-K | Other Events | ↗ |
| Sep 8, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Sep 8, 2026 | 424B3 | FORM 424B3 | ↗ |
| Aug 28, 2026 | S-1 | FORM S-1 | ↗ |
| Aug 28, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 13, 2026 | 10-Q | FORM 10-Q FOR JUN 2026 | ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 11, 2026 | 4 | ↗ | |
| Aug 3, 2026 | 8-K | Other Events | ↗ |
| Jul 20, 2026 | 424B5 | PROSPECTUS SUPPLEMENT | ↗ |
| Jul 20, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 10, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 8, 2026 | SCHEDULE 13G | ↗ | |
| Jun 8, 2026 | DEF 14C | DEF 14C | ↗ |
| May 29, 2026 | PRE 14C | PRELIMINARY INFORMATION STATEMENT | ↗ |
| May 29, 2026 | 8-K | Item 5.07 | ↗ |
| May 22, 2026 | SCHEDULE 13G | ↗ | |
| May 21, 2026 | SCHEDULE 13G | ↗ | |
| May 19, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| May 19, 2026 | 424B4 | PROSPECTUS | ↗ |
| May 18, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| May 18, 2026 | CORRESP | ↗ | |
| May 18, 2026 | CORRESP | ↗ | |
| May 14, 2026 | CORRESP | ↗ | |
| May 14, 2026 | CORRESP | ↗ | |
| May 13, 2026 | 10-Q | FORM 10-Q FOR MAR 2026 | ↗ |
| May 12, 2026 | S-1 | FORM S-1 | ↗ |
| May 4, 2026 | UPLOAD | ↗ | |
| Apr 28, 2026 | DRSLTR | ↗ | |
| Apr 28, 2026 | DRS | ↗ | |
| Apr 14, 2026 | 4 | ↗ | |
| Apr 9, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 3, 2026 | 10-K | FORM 10-K FOR DEC 2025 | ↗ |
| Mar 31, 2026 | NT 10-K | EXTENSION | ↗ |